Table 5.
Cancer Screening Test Rates by Provider Designation and Model Prediction of “My Patient”
| Variable | Population, N (%) | Provider Designation, N (%) | Model Prediction, N (%) | ||||
|---|---|---|---|---|---|---|---|
| “My Patient” | “Not My Patient” | P Value* | “My Patient” | “Not My Patient” | P Value* | ||
| Breast cancer, Mammography† | 2,636 (82.7%) | 1,917 (85.9%) | 719 (74.4%) | .01 | 1,740 (87.9%) | 896 (72.7%) | <.001 |
| Cervical cancer, Pap Smear‡ | 8,242 (82.7%) | 5,231 (83.8%) | 3,011 (80.7%) | .77 | 4,356 (84.9%) | 3,886 (80.2%) | .20 |
| Colorectal cancer§ | 4,336 (47.6%) | 3,256 (48.7%) | 1,080 (44.1%) | .74 | 2,975 (50.3%) | 1,361 (41.6%) | .02 |
P-values comparing actual and predicted patient loyalty designation to the provider using multiple regression modeling controlling for individual provider cluster with general estimating equation methods
Mammogram performed over the prior 2 years in eligible women aged 52 to 69 years old
Papanicolaou (Pap) smear performed over the prior 3 years in eligible women aged 18 to 65 years old
Colorectal cancer screening test performed in all patients aged 52 to 69 years old: colonoscopy in the prior 10 years; flexible sigmoidoscopy or double contrast barium enema in the prior 5 years; or fecal occult blood test in the prior year